These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21765859)

  • 1. Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy.
    Barnard DL; Kumaki Y
    Future Virol; 2011 May; 6(5):615-631. PubMed ID: 21765859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.
    Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe acute respiratory syndrome vs. the Middle East respiratory syndrome.
    Hui DS; Memish ZA; Zumla A
    Curr Opin Pulm Med; 2014 May; 20(3):233-41. PubMed ID: 24626235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses.
    Fung SY; Yuen KS; Ye ZW; Chan CP; Jin DY
    Emerg Microbes Infect; 2020; 9(1):558-570. PubMed ID: 32172672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins.
    de Wilde AH; Wannee KF; Scholte FE; Goeman JJ; Ten Dijke P; Snijder EJ; Kikkert M; van Hemert MJ
    J Virol; 2015 Aug; 89(16):8318-33. PubMed ID: 26041291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naturally Occurring Animal Coronaviruses as Models for Studying Highly Pathogenic Human Coronaviral Disease.
    Kenney SP; Wang Q; Vlasova A; Jung K; Saif L
    Vet Pathol; 2021 May; 58(3):438-452. PubMed ID: 33357102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2.
    Sohrab SS; Suhail M; Kamal MA; Ahmad F; Azhar EI
    Curr Pharm Des; 2020; 26(41):5286-5292. PubMed ID: 32954998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence and Re-emergence of Human Coronaviruses: Spike Protein as the Potential Molecular Switch and Pharmaceutical Target.
    Ahmad F; Kamal MA; Tekwani BL
    Curr Pharm Des; 2021; 27(33):3566-3576. PubMed ID: 33327904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
    Deng X; Buckley AC; Pillatzki A; Lager KM; Faaberg KS; Baker SC
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32554697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models of Middle East respiratory syndrome coronavirus infection.
    van Doremalen N; Munster VJ
    Antiviral Res; 2015 Oct; 122():28-38. PubMed ID: 26192750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.
    Lai CC; Shih TP; Ko WC; Tang HJ; Hsueh PR
    Int J Antimicrob Agents; 2020 Mar; 55(3):105924. PubMed ID: 32081636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Searching for animal models and potential target species for emerging pathogens: Experience gained from Middle East respiratory syndrome (MERS) coronavirus.
    Vergara-Alert J; Vidal E; Bensaid A; Segalés J
    One Health; 2017 Jun; 3():34-40. PubMed ID: 28616501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
    Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Pathogenesis of Bovine and Porcine Respiratory Coronaviruses in the Animal Host Species and SARS-CoV-2 in Humans.
    Saif LJ; Jung K
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32522830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of Nonstructural Protein 1 from SARS-CoV-2.
    Clark LK; Green TJ; Petit CM
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33234675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections.
    Schwartz DA; Graham AL
    Viruses; 2020 Feb; 12(2):. PubMed ID: 32050635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral and Cytoprotective Effect of Zinc (Yasad Bhasma) Based Nanoformulations Against Bovine Coronavirus.
    Manuja A; Kumar B; Chhabra D; Brar B; Riyesh T; Pal Y; Bhattacharya TK; Prasad M
    Indian J Microbiol; 2024 Sep; 64(3):1123-1131. PubMed ID: 39282188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tackling COVID-19 Using Antiviral Nanocoating's-Recent Progress and Future Challenges.
    Ghosal K
    Part Part Syst Charact; 2023 Jan; 40(1):2200154. PubMed ID: 36711425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.